Dare Bioscience, Inc. Forecast, price target & analysts
Dare Bioscience, Inc. Target price 2026 - Analyst rating & recommendation
Dare Bioscience, Inc. Classifications & Recommendation
Dare Bioscience, Inc. Price Target
| Target Price | $8.16 |
| Price | $0.74 |
| Potential |
1,001.96%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Dare Bioscience, Inc. 2027 .
The average Dare Bioscience, Inc. target price is $8.16.
This is
1,001.96%
register free of charge
$12.60
1,601.55%
register free of charge
$5.05
581.97%
register free of charge
|
|
| A rating was issued by 9 analysts: 8 Analysts recommend Dare Bioscience, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Dare Bioscience, Inc. stock has an average upside potential 2027 of
1,001.96%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 1.03 | 2.77 |
| 10,200.00% | 169.13% | |
| Net Margin | -1,300.97% | -502.38% |
| 96.79% | 61.38% |
5 Analysts have issued a sales forecast Dare Bioscience, Inc. 2026 . The average Dare Bioscience, Inc. sales estimate is
This results in the following potential growth metrics:
5 Dare Bioscience, Inc. Analysts have issued a net profit forecast 2026. The average Dare Bioscience, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.20 | -0.92 |
| 150.00% | 23.33% | |
| P/E | negative | |
| EV/Sales | 3.30 |
5 Analysts have issued a Dare Bioscience, Inc. forecast for earnings per share. The average Dare Bioscience, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Dare Bioscience, Inc....
Current Dare Bioscience, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 02 2025 |
| Maxim Group |
Locked
➜
Locked
|
Locked | Sep 04 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 17 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 15 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 24 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 02 2025 |
|
Locked
Maxim Group:
Locked
➜
Locked
|
Sep 04 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 01 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 17 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 15 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 24 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
